Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Mar 2026 and Jun 2026.
- Largest single sale: $857K (3,405 shares) of Ligand Pharmaceuticals Inc on Jun 10, 2026. Filing
- Last sale before this period: Nov 27, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ligand Pharmaceuticals Inc (LGND) | Director | Feb 10, 2011 | Jun 12, 2026 |
| Immunome Inc. (IMNM) | Former Director | Oct 1, 2020 | Jun 12, 2023 |
| Pfizer (PFE) | Former Senior Vice President | Jan 9, 2004 | Oct 17, 2007 |
| Thermo Fisher Scientific (TMO) | Former Director | Mar 10, 2004 | May 25, 2006 |
Also a director at
Immunome Inc. (IMNM) (no filing in the last 18 months), Thermo Fisher Scientific (TMO) (no filing in the last 18 months)
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 10, 2026, Ligand Pharmaceuticals Inc: sold 4,591 shares for $1.2M, no plan disclosed. 1 filing: 1
- Jun 5, 2026, Ligand Pharmaceuticals Inc: 836 shares granted. 1 filing: 1
- Mar 6, 2026, Ligand Pharmaceuticals Inc: sold 2,161 shares for $434K, no plan disclosed; 2,161 shares acquired by exercising options. 1 filing: 1
- Nov 7, 2025, Ligand Pharmaceuticals Inc: sold 4,179 shares for $859K, no plan disclosed; 4,179 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.